SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — CytomX Therapeutics Inc. (CTMX) on Thursday reported a loss of $20.7 million in its second quarter.

The South San Francisco, California-based company said it had a loss of 9 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The biopharmaceutical company posted revenue of $1.4 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTMX at https://www.zacks.com/ap/CTMX